Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (595,694)	$ (701,454)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	994	1,897
Stock-based compensation expense	6,000	153,224
Changes in assets and liabilities:
Grant funds and other receivables	(451,906)	(38,463)
Prepaid expenses and other current assets	27,425	(30)
Accounts payable and accrued expenses	654,561	267,465
Total adjustments	237,074	384,093
Net cash used in operating activities	(358,620)	(317,361)
Cash flows from investing activities:
Purchase of property and equipment		(4,272)
Net cash used in investing activities		(4,272)
Cash flows from financing activities:
Net proceeds from sale of preferred stock	300,000	240,000
Principal repayment of note payable	(2,914)	(2,083)
Net cash provided by financing activities	297,086	237,917
Net increase (decrease) in cash and cash equivalents	(61,534)	(83,716)
Cash and cash equivalents at beginning of period	283,341	259,701
Cash and cash equivalents at end of period	$ 221,807	$ 175,985